Thomas Muley

University Hospital Heidelberg

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Cancer Biology Cancer Biology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Georg Johnen

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr Univer

GERMANY

View details

Judith Schenz

University Hospital Heidelberg

GERMANY

View details

Qianxin Wu

Wellcome Sanger Institute

UNITED KINGDOM

View details

Dirk Taeger

Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr Univer

GERMANY

View details

Arash Ash Alizadeh

Professor of Medicine

Stanford University School of Medicine

UNITED STATES

View details

Marc Schneider

Heidelberg University

GERMANY

View details

Marina Laplana

Lecturer in Genetics

Universitat de Girona

SPAIN

View details

Hauke Winter

Department Head / Prof. Dr. med

Heidelberg University

GERMANY

View details

Soma Jyothula

Associate Professor

UT Physicians

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Muley

Research Interests

Explore related searches

Contact this professor

Articles (10)

Combination of calretinin, MALAT1, and GAS5 as a potential prognostic biomarker to predict disease progression in surgically treated mesothelioma patients

Peripheral Inflammation Featuring Eosinophilia or Neutrophilia Is Associated with the Survival and Infiltration of Eosinophils within the Tumor among Various Histological Subgroups of Patients with NSCLC

CYFRA 21-1, CA 125 and CEA provide additional prognostic value in NSCLC patients with stable disease at first CT scan

Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission

High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD

Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection

Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and <i>SREBF1</i> Gene.

Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS)

Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

Collaborators (9)

Georg Johnen

Judith Schenz

Qianxin Wu

Dirk Taeger

Arash Ash Alizadeh

Marc Schneider

Marina Laplana

Hauke Winter

Soma Jyothula

Make your next move.